Clinica Baviera SA
MAD:CBAV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clinica Baviera SA
MAD:CBAV
|
ES |
Intrinsic Value
The intrinsic value of Clinica Baviera SA (CBAV) under the Base Case is 53.04 EUR per share.
Compared with the current market price of 54.4 EUR, the stock appears
Overvalued by 3% .
The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 9% a year over the next five years, less than half its five-year pace of 20%. If revenue grew at its five-year pace of 20%, the estimate would be about €91.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Clinica Baviera Does
Clinica Baviera SA is an eye-care company that runs a network of ophthalmology clinics. It focuses on diagnosing and treating vision problems, with a strong emphasis on elective procedures such as laser vision correction, cataract surgery, and other medical and surgical treatments for common eye conditions. Its customers are individual patients who pay for care themselves or through private health insurance, depending on the treatment and market.
- Headquarters
- Spain ES
- Employees
- 1 861
- IPO date
- Jan 1, 2000
Clinica Baviera has a narrow economic moat
Clinica Baviera SA has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
Clinica Baviera SA
Earnings Waterfall
Clinica Baviera SA
The intrinsic value for Clinica Baviera SA (CBAV) under the Base Case is 53.04 EUR.
Compared with the current market price of 54.4 EUR, the stock appears Overvalued by 3% .